Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 6,088 | 3,495 | 6,151 | 5,034 | 5,062 |
| Operating Income | -6,088 | -3,495 | -6,151 | -5,034 | -5,062 |
| Other Income | 1,643 | 856 | 2,756 | -5,078 | 3,853 |
| Pre-tax Income | -4,445 | -2,639 | -3,395 | -10,112 | -1,209 |
| Net Income Continuous | -4,445 | -2,639 | -3,395 | -10,112 | -1,209 |
| Net Income | $-4,445 | $-2,639 | $-3,395 | $-10,112 | $-1,209 |
| EPS Basic Total Ops | -74.96 | -97.45 | -123.69 | -382.31 | -56.22 |
| EPS Basic Continuous Ops | -76.39 | -99.73 | -124.20 | -382.30 | -54.45 |
| EPS Diluted Total Ops | -74.96 | -97.45 | -123.69 | -382.31 | -56.22 |
| EPS Diluted Continuous Ops | -76.39 | -99.73 | -124.20 | -382.30 | -54.45 |
| EBITDA(a) | $-6,044 | $-3,449 | $-6,095 | $-4,982 | $-5,016 |